NEUMUNAVI Trademark

Trademark Overview

On Tuesday, August 17, 2021, a trademark application was filed for NEUMUNAVI with the United States Patent and Trademark Office. The USPTO has given the NEUMUNAVI trademark a serial number of 90886345. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 19, 2024. This trademark is owned by Merck Sharp & Dohme Corp.. The NEUMUNAVI trademark is filed in the Pharmaceutical Products category with the following description:

Human vaccine preparations
neumunavi

General Information

Serial Number90886345
Word MarkNEUMUNAVI
Filing DateTuesday, August 17, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements

Goods and ServicesHuman vaccine preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMERCK SHARP & DOHME LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065
Party NameMerck Sharp & Dohme Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889
Party NameMerck Sharp & Dohme Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889

Trademark Events

Event DateEvent Description
Wednesday, April 13, 2022ASSIGNED TO EXAMINER
Friday, August 20, 2021NEW APPLICATION ENTERED
Tuesday, October 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2023SOU EXTENSION 1 GRANTED
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 29, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 10, 2023SOU EXTENSION 1 FILED
Monday, July 17, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 17, 2023SOU EXTENSION 2 FILED
Thursday, January 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 17, 2023SOU EXTENSION 2 GRANTED
Wednesday, July 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 4, 2024SOU TEAS EXTENSION RECEIVED
Saturday, January 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 26, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, September 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 6, 2023ASSIGNED TO EXAMINER
Thursday, January 4, 2024SOU EXTENSION 3 FILED
Thursday, January 4, 2024SOU EXTENSION 3 GRANTED
Friday, March 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 1, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 19, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, August 19, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, March 1, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

neumunavi preparations vaccine human